Watch the 22 sessions from SOSV Climate Tech Summit!

Renegade Bio

Fast, accessible, and secure triage for COVID-19

Team

Craig Rouskey

CEO & Co-Founder / CSO & Co-Founder

Gabriel Paulino

COO and Co-Founder / CEO

Company details

Renegade.bio invented an improvement on the CDC testing method for COVID-19, turning four reactions into a single-step that doesn’t require RNA extraction. By dramatically improving turnaround time and capacity of testing machines, the RenegadeXP™method is 70% cheaper and takes half the time of a standard CDC test, with a net >4x increase in throughput. Renegade.bio has submitted an emergency use authorization application to the FDA for its RenegadeXP™ test.

In mid-April, Renegade.bio partnered with a well-known genetic research institute in New York City to operate a CLIA-certified laboratory to test government workers and medical personnel. The New York City laboratory is capable of running 1,300 tests every day, and will grow to serve a capacity of at least 20,000 tests per week by the end of June.

Get In Touch with Renegade Bio

Please tell us a little bit about yourself and why you'd like to get connected. Renegade Bio + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.